Malaria vaccine (MSP3-LSP) - Vac4AllAlternative Names: MSP3-LSP aduvanted in Aluminium Hydroxide (AIOH) - Vac4All; MSP3-LSP/AIOH malaria vaccine - Vac4All
Latest Information Update: 09 Feb 2016
At a glance
- Originator Vac4All
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Falciparum malaria
Most Recent Events
- 01 May 2011 Phase-II clinical trials in Falciparum malaria (Prevention, In children) in Mali (SC)